Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
C$36.34
C$28.20
C$37.10
C$538.81M1.1423,747 shs76,741 shs
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$15.19
$8.13
$19.08
$24.33M0.4122,155 shs237,144 shs
MTY Food Group Inc. stock logo
MTY
MTY Food Group
C$40.15
-0.1%
C$42.43
C$36.79
C$53.16
C$936.19M1.9562,697 shs57,395 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
0.00%0.00%0.00%0.00%+27.96%
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
0.00%0.00%0.00%0.00%+32.34%
MTY Food Group Inc. stock logo
MTY
MTY Food Group
-1.08%-8.03%-0.37%-0.67%-14.92%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
0.2861 of 5 stars
0.00.00.04.20.60.80.0
MTY Food Group Inc. stock logo
MTY
MTY Food Group
3.0279 of 5 stars
3.20.01.70.01.10.82.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
2.00
HoldC$36.00∞ Upside
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
0.00
N/AN/AN/A
MTY Food Group Inc. stock logo
MTY
MTY Food Group
2.33
HoldC$50.5025.78% Upside

Current Analyst Ratings Breakdown

Latest AW.UN, CARA, and MTY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/14/2025
MTY Food Group Inc. stock logo
MTY
MTY Food Group
Acumen Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuyC$60.00 ➝ C$50.00
7/14/2025
MTY Food Group Inc. stock logo
MTY
MTY Food Group
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$51.00 ➝ C$48.00
6/18/2025
MTY Food Group Inc. stock logo
MTY
MTY Food Group
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/22/2025
MTY Food Group Inc. stock logo
MTY
MTY Food Group
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetSector PerformC$51.00
5/16/2025
MTY Food Group Inc. stock logo
MTY
MTY Food Group
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/6/2025
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutralC$38.00 ➝ C$36.00
(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
C$55.30M0.00N/A35.08C$13.82 per share0.00
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$7.14M0.00N/AN/A$12.58 per share0.00
MTY Food Group Inc. stock logo
MTY
MTY Food Group
C$1.13B0.83C$1.51 per share26.52C$35.02 per share1.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
C$30.86MC$1.9818.65N/AN/A55.81%11.28%7.90%N/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
-$118.51M-$21.01N/AN/AN/A-1,099.76%-367.97%-107.43%N/A
MTY Food Group Inc. stock logo
MTY
MTY Food Group
C$93.69MC$4.0010.030.758.30%11.66%4.18%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
C$1.925.22%N/A96.97%N/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
N/AN/AN/AN/AN/A
MTY Food Group Inc. stock logo
MTY
MTY Food Group
C$1.122.79%N/A27.97%N/A

Latest AW.UN, CARA, and MTY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/5/2025
MTY Food Group Inc. stock logo
MTY
MTY Food Group
QuarterlyC$0.333.25%8/5/20258/15/20258/15/2025
5/1/2025
MTY Food Group Inc. stock logo
MTY
MTY Food Group
QuarterlyC$0.333.41%5/1/20255/15/20255/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
16.97
3.51
2.57
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
N/A
4.77
4.71
MTY Food Group Inc. stock logo
MTY
MTY Food Group
142.67
0.61
0.57

Institutional Ownership

CompanyInstitutional Ownership
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
11.06%
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
44.66%
MTY Food Group Inc. stock logo
MTY
MTY Food Group
19.03%

Insider Ownership

CompanyInsider Ownership
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
2.23%
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
3.10%
MTY Food Group Inc. stock logo
MTY
MTY Food Group
16.54%
CompanyEmployeesShares OutstandingFree FloatOptionable
A and W Revenue Royalties Income Fund stock logo
AW.UN
A and W Revenue Royalties Income Fund
N/A14.59 millionN/ANot Optionable
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
804.57 million4.43 millionOptionable
MTY Food Group Inc. stock logo
MTY
MTY Food Group
7,32623.32 millionN/ANot Optionable

Recent News About These Companies

Brokers Issue Forecasts for MTY Food Group FY2025 Earnings
FY2027 EPS Estimates for MTY Food Group Lowered by Analyst
MTY Food Group sees 110% rise in Q2 2025 net income
MTY reports Q2 for Fiscal 2025
FY2025 EPS Forecast for MTY Food Group Decreased by Analyst
FY2026 EPS Estimate for MTY Food Group Decreased by Analyst

New MarketBeat Followers Over Time

Media Sentiment Over Time

A and W Revenue Royalties Income Fund stock logo

A and W Revenue Royalties Income Fund TSE:AW.UN

A&W Revenue Royalties Income Fund, a limited purpose trust, holds investment in A&W Trade Marks Inc., through its ownership interest in A&W Trade Marks Limited Partnership, owns the A&W trade-marks used in the A&W quick service restaurant business in Canada. The company licenses A&W trade-marks to A&W Food Services of Canada Inc. A&W Revenue Royalties Income Fund was founded in 2001 and is based in North Vancouver, Canada.

Cara Therapeutics stock logo

Cara Therapeutics NASDAQ:CARA

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

MTY Food Group stock logo

MTY Food Group TSE:MTY

C$40.15 -0.05 (-0.12%)
As of 03:29 PM Eastern

MTY Food Group Inc. operates and franchises quick-service, fast-casual, and casual dining restaurants in Canada, the United States, and internationally. It also sells retail products under a multitude of banners. The company was formerly known as iNsu Innovations Group Inc. and changed its name to MTY Food Group Inc. in July 2003. MTY Food Group Inc. was founded in 1979 and is headquartered in Saint-Laurent, Canada.